Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 1c, Lowers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Zimmer Biomet (ZBH) PT Lowered to $175 at Jefferies
November 5, 2021 8:17 AM EDTJefferies analyst Raj Denhoy lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $200.00) while maintaining a Buy rating.
The analyst commented, "Key 2Q post call details: 1) Delta/Staffing impacts are expected to persist into 4Q at heightened level, 2) China VBP... More
Zimmer Biomet (ZBH) PT Lowered to $175 at Truist Securities
November 4, 2021 6:09 PM EDTTruist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining a Buy rating.
The analyst commented, "The third quarter was another noisy event for Zimmer Biomet headlined by COVID, staffing, and VBP headwinds that impacted... More
Zimmer Biomet (ZBH) PT Lowered to $175 at Needham & Company
November 4, 2021 1:45 PM EDTNeedham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $187.00) while maintaining a Strong Buy rating.
The analyst commented, "ZBH's 3Q21 revenue missed while EPS beat consensus. Growth slowed due to procedure disruption and a tougher comp... More
